Skip to Main Content

Mohamed Fahmy

Principal Scientist and CIIM Partner, Global Computational Biology and Digital Sciences

Dr. Fahmy is a Principal Scientist and GCBDS Partner for the therapeutic area (TA) of cancer immunology and immune modulation (CIIM) at Department of Global Computational Biology and Digital Sciences (GCBDS), Boehringer Ingelheim (BI), Biberach, Germany. In his role, he oversees the computational biology analysis to drive the discovery research process for CIIM portfolio and to execute the TA strategy for identifying new targets and novel therapeutic concepts. Before joining BI, Dr. Fahmy was the head of the Integrative OMICs Analysis group at Rostock University Medical Center, Rostock, Germany. His research interests include biological data integration, developing integrative bioinformatics methods for precision medicine, systems biology, drug combination predictions, Radiogenomics and cancer genomics. Dr. Fahmy received his BSc degree in systems and biomedical engineering with highest honors from Cairo University before getting a full grant to obtain an IT diploma in the field of software engineering from the Information Technology Institute (ITI) in Egypt. Dr. Fahmy worked for ESRINEA as a senior team leader focusing on developing and integrating enterprise IT solutions. He received his MSc degree from the school of computer science in Nottingham University, UK and his PhD degree in computer science (specialization: bioinformatics) from Saarland University, Saarbrucken, Germany. He was a visiting research associate in international research centres such as National Institute of Informatics (NII) in Tokyo, Japan and the Centre for Bioinformatics (CBI) in Saarbrucken, Germany as well as the Royal Perth Hospital, University of west Australia in Perth, Australia.